search
Back to results

Intelligibility Assessment for Parkinson's Disease

Primary Purpose

Parkinson Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Understand Me For Life
Sponsored by
Long Island University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Parkinson Disease focused on measuring intelligibility, voice disorders, dysarthria

Eligibility Criteria

30 Years - 85 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Speakers with PD:

Inclusion Criteria:

  • Have a medical diagnosis of Parkinson's disease
  • Have experienced changes in your voice (e.g., your voice has "lost its strength") and your voice is a current concern
  • Have not received individual speech therapy for the past 2 years (group therapy is ok)
  • Have a stable medication schedule
  • Have not received DBS (Deep Brain Stimulation)
  • Are a native speaker of American English

Exclusion Criteria:

  • If criteria above are not met

Healthy controls:

Inclusion Criteria:

  • Be a native speaker of American English
  • Have no history of neurological impairment
  • Have no history of speech or language problems

Exclusion Criteria:

  • If criteria above are not met

Listeners:

Inclusion Criteria:

  • Be a native speaker of American English
  • Be between 18-55 years old
  • Have no history of speech-language-hearing problems
  • Pass a free hearing screening
  • Have received the Covid19 vaccine

Exclusion Criteria:

  • If criteria above are not met

Sites / Locations

  • Long Island University

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Speakers

Arm Description

Participants will be recording sentences using a customized app, which is the focus of the current investigation. There is no arm per se, as the current investigation does not involve an intervention. The current investigation aims at developing and pilot testing an app.

Outcomes

Primary Outcome Measures

Transcription scores
Percent of words correctly transcribed

Secondary Outcome Measures

Full Information

First Posted
March 24, 2021
Last Updated
April 4, 2022
Sponsor
Long Island University
search

1. Study Identification

Unique Protocol Identification Number
NCT04829006
Brief Title
Intelligibility Assessment for Parkinson's Disease
Official Title
Automatic Assessment of Intelligibility in Individuals With Parkinson's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
April 1, 2021 (Actual)
Primary Completion Date
March 31, 2022 (Actual)
Study Completion Date
April 4, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Long Island University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The investigators aim at testing the efficacy of an app to measure sentence intelligibility in noise in speakers with Parkinson's disease and in healthy controls.
Detailed Description
Close to 90% of people with Parkinson's disease develop voice problems during the course of the disease. These problems lead to reduced intelligibility, which entails a subsequent reduction in social participation and overall quality of life. The current study will focus on developing and pilot-testing an app to measure the intelligibility of people with PD and of healthy controls. In order to test the app's efficacy, speakers will read a set of 50 sentences that will be embedded in noise for measurement purposes. A group of listeners will also transcribe the spoken sentences to correlate their performance to that of the app. The ultimate purpose of this investigation is to improve self-monitoring and self-sufficiency in people with PD. The study is expected to last 12 months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Parkinson Disease
Keywords
intelligibility, voice disorders, dysarthria

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
70 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Speakers
Arm Type
Other
Arm Description
Participants will be recording sentences using a customized app, which is the focus of the current investigation. There is no arm per se, as the current investigation does not involve an intervention. The current investigation aims at developing and pilot testing an app.
Intervention Type
Device
Intervention Name(s)
Understand Me For Life
Intervention Description
The aim of the current investigation is to test the efficacy of an app to measure sentence intelligibility in noise in speakers with Parkinson's disease and in healthy controls.
Primary Outcome Measure Information:
Title
Transcription scores
Description
Percent of words correctly transcribed
Time Frame
30 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Speakers with PD: Inclusion Criteria: Have a medical diagnosis of Parkinson's disease Have experienced changes in your voice (e.g., your voice has "lost its strength") and your voice is a current concern Have not received individual speech therapy for the past 2 years (group therapy is ok) Have a stable medication schedule Have not received DBS (Deep Brain Stimulation) Are a native speaker of American English Exclusion Criteria: If criteria above are not met Healthy controls: Inclusion Criteria: Be a native speaker of American English Have no history of neurological impairment Have no history of speech or language problems Exclusion Criteria: If criteria above are not met Listeners: Inclusion Criteria: Be a native speaker of American English Be between 18-55 years old Have no history of speech-language-hearing problems Pass a free hearing screening Have received the Covid19 vaccine Exclusion Criteria: If criteria above are not met
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gemma Moya Gale, Ph.D.
Organizational Affiliation
Long Island University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Long Island University
City
Brooklyn
State/Province
New York
ZIP/Postal Code
11201
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Intelligibility Assessment for Parkinson's Disease

We'll reach out to this number within 24 hrs